Quantifying the Massive Pleiotropy of MicroRNA: a Human MicroRNA-disease Causal Association Database Generated with ChatGPT

Overview

Journal bioRxiv

Date 2024 Jul 19

PMID 39026876

Authors

K Rowan Wang

Julian Hecker

Michael J McGeachie

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are recognized as key regulatory factors in numerous human diseases, with the same miRNA often involved in several diseases simultaneously or being identified as a biomarker for dozens of separate diseases. While of evident biological importance, miRNA pleiotropy remains poorly understood, and quantifying this could greatly aid in understanding the broader role miRNAs play in health and disease. To this end, we introduce miRAIDD (miRNA Artificial Intelligence Disease Database), a comprehensive database of human miRNA-disease causal associations constructed using large language models (LLM). Through this endeavor, we provide two entirely novel contributions: 1) we systematically quantify miRNA pleiotropy, a property of evident translational importance; and 2) describe biological and bioinformatic characteristics of miRNAs which lead to increased pleiotropy. Further, we provide our code, database, and experience using AI LLMs to the broader research community.

References

Kim T, Croce C . MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med. 2023; 55(7):1314-1321. PMC: 10394030. DOI: 10.1038/s12276-023-01050-9. View

Gao Y, Jia K, Shi J, Zhou Y, Cui Q . A Computational Model to Predict the Causal miRNAs for Diseases. Front Genet. 2019; 10:935. PMC: 6786093. DOI: 10.3389/fgene.2019.00935. View

Ru Y, Kechris K, Tabakoff B, Hoffman P, Radcliffe R, Bowler R . The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014; 42(17):e133. PMC: 4176155. DOI: 10.1093/nar/gku631. View

Zhang Y, Tang S, Yang W, Du F . let-7b-5p suppresses the proliferation and migration of pulmonary artery smooth muscle cells via down-regulating IGF1. Clinics (Sao Paulo). 2022; 77:100051. PMC: 9156868. DOI: 10.1016/j.clinsp.2022.100051. View

Godard P, van Eyll J . Pathway analysis from lists of microRNAs: common pitfalls and alternative strategy. Nucleic Acids Res. 2015; 43(7):3490-7. PMC: 4402548. DOI: 10.1093/nar/gkv249. View

Ratwani R, Bates D, Classen D . Patient Safety and Artificial Intelligence in Clinical Care. JAMA Health Forum. 2024; 5(2):e235514. DOI: 10.1001/jamahealthforum.2023.5514. View

Jenike A, Halushka M . miR-21: a non-specific biomarker of all maladies. Biomark Res. 2021; 9(1):18. PMC: 7953557. DOI: 10.1186/s40364-021-00272-1. View

Karkera N, Acharya S, Palaniappan S . Leveraging pre-trained language models for mining microbiome-disease relationships. BMC Bioinformatics. 2023; 24(1):290. PMC: 10357883. DOI: 10.1186/s12859-023-05411-z. View

Chen Y, Wang X . miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2019; 48(D1):D127-D131. PMC: 6943051. DOI: 10.1093/nar/gkz757. View

10.

Panwar B, Omenn G, Guan Y . miRmine: a database of human miRNA expression profiles. Bioinformatics. 2017; 33(10):1554-1560. PMC: 6044334. DOI: 10.1093/bioinformatics/btx019. View

11.

Cui C, Zhong B, Fan R, Cui Q . HMDD v4.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res. 2023; 52(D1):D1327-D1332. PMC: 10767894. DOI: 10.1093/nar/gkad717. View

12.

Resnik D, Shamoo A . Reproducibility and Research Integrity. Account Res. 2016; 24(2):116-123. PMC: 5244822. DOI: 10.1080/08989621.2016.1257387. View

13.

Easterbrook P, Berlin J, Gopalan R, Matthews D . Publication bias in clinical research. Lancet. 1991; 337(8746):867-72. DOI: 10.1016/0140-6736(91)90201-y. View

14.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

15.

Enright A, John B, Gaul U, Tuschl T, Sander C, Marks D . MicroRNA targets in Drosophila. Genome Biol. 2004; 5(1):R1. PMC: 395733. DOI: 10.1186/gb-2003-5-1-r1. View

16.

Wang K, McGeachie M . DisiMiR: Predicting Pathogenic miRNAs Using Network Influence and miRNA Conservation. Noncoding RNA. 2022; 8(4). PMC: 9326518. DOI: 10.3390/ncrna8040045. View

17.

Huang Z, Shi J, Gao Y, Cui C, Zhang S, Li J . HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res. 2018; 47(D1):D1013-D1017. PMC: 6323994. DOI: 10.1093/nar/gky1010. View

18.

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

19.

Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y . MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010; 1359:14-21. DOI: 10.1016/j.brainres.2010.08.074. View

20.

Ardekani A, Naeini M . The Role of MicroRNAs in Human Diseases. Avicenna J Med Biotechnol. 2013; 2(4):161-79. PMC: 3558168. View